ArticleAnnals of medicine and surgery (2012)2022

Significant response to Pembrolizumab for metastatic cutaneous squamous cell carcinoma in patient with Netherton syndrome.

Salem M Tos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.